UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double U-Net CycleGAN for 3D MR to CT image synthesis

International journal for computer assisted radiology and surgery, 2023-01, Vol.18 (1), p.149-156

2023

Volltextzugriff (PDF)

Anterior cerebral falx plane in MR images to estimate the craniofacial midline

Scientific reports, 2023-10, Vol.13 (1), p.16489-16489, Article 16489

2023

Volltextzugriff (PDF)

Anatomical network modules of the human central nervous-craniofacial skeleton system

Frontiers in neurology, 2023-08, Vol.14, p.1164283-1164283

2023

Volltextzugriff (PDF)

Gut microbiota and oral cavity cancer: a two-sample bidirectional Mendelian randomization study

Frontiers in oncology, 2024-05, Vol.14, p.1389678-1389678

2024

Volltextzugriff (PDF)

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

Journal of experimental & clinical cancer research, 2012-08, Vol.31 (1), p.70-70, Article 70

2012

Volltextzugriff (PDF)

Development and Translational Application of a Minimal Physiologically Based Pharmacokinetic Model for a Monoclonal Antibody against Interleukin 23 (IL-23) in IL-23-Induced Psoriasis-Like Mice

The Journal of pharmacology and experimental therapeutics, 2018-04, Vol.365 (1), p.140-155

2018

Volltextzugriff (PDF)

Addition of fungal inoculum increases seed germination and protocorm formation in a terrestrial orchid

Global ecology and conservation, 2022-10, Vol.38, p.e02235, Article e02235

2022

Volltextzugriff (PDF)

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Clinical cancer research, 2021-04, Vol.27 (7), p.1836-1841

2021

Volltextzugriff (PDF)

Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma

Clinical & translational oncology, 2024-09, Vol.26 (9), p.2274-2295

2024

Volltextzugriff (PDF)

Simulation and circuit implementation of 12-scroll chaotic system

Chaos, solitons and fractals, 2015-06, Vol.75, p.127-133

2015

Volltextzugriff (PDF)

Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies

Disease markers, 2022-10, Vol.2022, p.1-13

2022

Volltextzugriff (PDF)

Quantitative systems pharmacology for rare disease drug development

Journal of pharmaceutical sciences, 2023-09, Vol.112 (9), p.2313-2320

2023

Volltextzugriff (PDF)

An MRI-only Three-dimensional Cephalometry Protocol based on the Integrated and Modular Architecture of the Human Head

Current medical imaging reviews, 2024-01, Vol.20

2024

Volltextzugriff (PDF)

Development of a minimal physiologically-based pharmacokinetic/pharmacodynamic model to characterize target cell depletion and cytokine release for T cell-redirecting bispecific agents in humans

European journal of pharmaceutical sciences, 2020-04, Vol.146, p.105260, Article 105260

2020

Volltextzugriff (PDF)

Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma

American journal of translational research, 2020-01, Vol.12 (11), p.7160-7173

2020

Volltextzugriff (PDF)

Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine‐ and Platinum‐Based Chemotherapy

The oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.318-324

2021

Volltextzugriff (PDF)

FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

Clinical cancer research, 2024-04, Vol.30 (7), p.1226-1231

2024

Volltextzugriff (PDF)

Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein–Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6

The AAPS journal, 2016-05, Vol.18 (3), p.767-776

2016

Volltextzugriff (PDF)

Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents

mAbs, 2018-08, Vol.10 (6), p.876-889

2018

Volltextzugriff (PDF)

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer

Clinical cancer research, 2021-04, Vol.27 (8), p.2126-2129

2021

Volltextzugriff (PDF)

Case of infertility

Zhōngguó zhēnjiǔ, 2015-06, Vol.35 (6), p.560

2015

Volltextzugriff (PDF)

Integrated bioinformatic analysis identifies COL4A3, COL4A4, and KCNJ1 as key biomarkers in Wilms tumor

International journal of clinical and experimental pathology, 2021-01, Vol.14 (2), p.196-208

2021

Volltextzugriff (PDF)

UC-GAN for MR to CT Image Synthesis

Artificial Intelligence in Radiation Therapy, 2019, p.146-153

2019

Volltextzugriff (PDF)

Abstract 2085: Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize tumor killing effect of an anti-VISTA monoclonal antibody in tumor bearing mice

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2085-2085

2016

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(170)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Double U-Net CycleGAN for 3D MR to CT image synthesis

Anterior cerebral falx plane in MR images to estimate the craniofacial midline

Anatomical network modules of the human central nervous-craniofacial skeleton system

Gut microbiota and oral cavity cancer: a two-sample bidirectional Mendelian randomization study

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

Development and Translational Application of a Minimal Physiologically Based Pharmacokinetic Model for a Monoclonal Antibody against Interleukin 23 (IL-23) in IL-23-Induced Psoriasis-Like Mice

Addition of fungal inoculum increases seed germination and protocorm formation in a terrestrial orchid

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma

Simulation and circuit implementation of 12-scroll chaotic system

Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies

Quantitative systems pharmacology for rare disease drug development

An MRI-only Three-dimensional Cephalometry Protocol based on the Integrated and Modular Architecture of the Human Head

Development of a minimal physiologically-based pharmacokinetic/pharmacodynamic model to characterize target cell depletion and cytokine release for T cell-redirecting bispecific agents in humans

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma

Benefit–Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine‐ and Platinum‐Based Chemotherapy

FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein–Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6

Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer

Case of infertility

Integrated bioinformatic analysis identifies COL4A3, COL4A4, and KCNJ1 as key biomarkers in Wilms tumor

UC-GAN for MR to CT Image Synthesis

Abstract 2085: Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize tumor killing effect of an anti-VISTA monoclonal antibody in tumor bearing mice

Suchergebnisse filtern